Abliva AB Valuation
| ABLI Stock | SEK 0.43 0.01 2.38% |
Abliva AB is overvalued. Abliva AB shows a prevailing Real Value of kr0.3 per share. The current price of the firm is kr0.43. Our model approximates the value of Abliva AB from analyzing the firm fundamentals such as Return On Equity of -0.8, current valuation of 103.38 M, and Shares Owned By Insiders of 7.79 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Abliva AB's price fluctuation is out of control at this time. Calculation of the real value of Abliva AB is based on 3 months time horizon. Increasing Abliva AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Abliva AB's intrinsic value may or may not be the same as its current market price of 0.43, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.43 | Real 0.3 | Hype 0.43 |
The intrinsic value of Abliva AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Abliva AB's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Abliva AB helps investors to forecast how Abliva stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Abliva AB more accurately as focusing exclusively on Abliva AB's fundamentals will not take into account other important factors: Abliva AB Total Value Analysis
Abliva AB is presently anticipated to have takeover price of 103.38 M with market capitalization of 316.92 M, debt of 92 K, and cash on hands of 47.98 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Abliva AB fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
103.38 M | 316.92 M | 92 K | 47.98 M |
Abliva AB Investor Information
About 49.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.97. Some equities with similar Price to Book (P/B) outperform the market in the long run. Abliva AB recorded a loss per share of 0.31. The entity had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Abliva AB's historical financial statements, Abliva AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Abliva AB Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Abliva AB has an asset utilization ratio of 0.26 percent. This implies that the Company is making kr0.002563 for each dollar of assets. An increasing asset utilization means that Abliva AB is more efficient with each dollar of assets it utilizes for everyday operations.Abliva AB Ownership Allocation
Abliva AB holds a total of 1.06 Billion outstanding shares. 30% of Abliva AB outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Abliva AB Profitability Analysis
The company reported the revenue of 151 K. Net Loss for the year was (123.49 M) with loss before overhead, payroll, taxes, and interest of (103.54 M).About Abliva AB Valuation
The stock valuation mechanism determines Abliva AB's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Abliva AB based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Abliva AB. We calculate exposure to Abliva AB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Abliva AB's related companies.Abliva AB , a pharmaceutical company, engages in the research and development of mitochondrial medicine. Abliva AB was incorporated in 2000 and is headquartered in Lund, Sweden. Abliva AB is traded on Stockholm Stock Exchange in Sweden.
8 Steps to conduct Abliva AB's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Abliva AB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Abliva AB's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Abliva AB's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Abliva AB's revenue streams: Identify Abliva AB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Abliva AB's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Abliva AB's growth potential: Evaluate Abliva AB's management, business model, and growth potential.
- Determine Abliva AB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Abliva AB's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Abliva Stock Analysis
When running Abliva AB's price analysis, check to measure Abliva AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abliva AB is operating at the current time. Most of Abliva AB's value examination focuses on studying past and present price action to predict the probability of Abliva AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abliva AB's price. Additionally, you may evaluate how the addition of Abliva AB to your portfolios can decrease your overall portfolio volatility.